Partial Economic Evaluation
A study examining either the costs or the outcomes of an intervention, or both without comparison to an alternative, short of a full economic evaluation.
Explore comprehensive, evidence-informed explanations of key health economics concepts, including their development, application and relationships to other concepts. Published entries are validated through human expert review.
A study examining either the costs or the outcomes of an intervention, or both without comparison to an alternative, short of a full economic evaluation.
A Monte Carlo technique estimating a dynamic system's state over time using weighted sample points, called particles, updated as new data arrive.
A population-based optimisation technique inspired by flocking behaviour, in which candidate solutions adjust position based on their own and the group's best results.
An oncology modelling technique estimating the proportion of a cohort in each health state using separately fitted survival curves for different endpoints, rather than modelling transitions.
A measurable change in health, function, symptoms, quality of life or survival experienced by a patient.
A missing data modelling approach stratifying analysis by the observed pattern of missingness, rather than assuming one model applies to everyone.
The length of time required for the cumulative cash inflows from an investment to equal its initial cost.
A measure quantifying the strength and direction of the linear relationship between two continuous variables, ranging from negative one to positive one.
A standard unit expressing a capitated payment as the fixed monthly amount received per enrolled member, regardless of services actually used.
A descriptive statistic indicating the value below which a specified percentage of observations in a dataset fall.
The proportion of a population with a particular condition at any point during a specified period, combining existing and newly developed cases.
A non-parametric hypothesis test determining significance by repeatedly rearranging observed data labels to build an empirical distribution under the null hypothesis.
The viewpoint adopted in an economic evaluation that determines which categories of cost and outcome are included, such as payer, patient, or societal.
A variant of the log-rank test using a specific weighting scheme offering statistical efficiency advantages under certain patterns of censoring.
The study of how the body absorbs, distributes, metabolises, and eliminates a drug over time, covering bioavailability, clearance, and half-life.
A numerical estimate of expected future healthcare costs calculated using prescription drug utilisation patterns as an indicator of health status.
A survival model dividing follow-up into distinct segments, each modelled with a separate, often simpler function, letting the hazard shape vary in steps.
A single numerical value representing the best available estimate of an unknown parameter, unlike an interval estimate conveying its uncertainty range.
The proportion of a population found to have a particular condition at a single specific point in time, unlike period prevalence or incidence.
A discrete probability distribution describing the number of times an event occurs within a fixed interval, assuming independence and a constant average rate.